Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease.

Recurrence of Clostridium difficile infection (CDI) places a major burden on the healthcare system. Previous studies have suggested that specific C. difficile strains, or ribotypes, are associated with severe disease and/or recurrence.